AUtoimmunity PRofile in INterferon β-1a treated multiple sclerosis patients.: The AUPRIN study:: comparison of 2 different dosage of subcutaneous interferon-β-1a

被引：0
|
作者：
Verdun, E
Ricci, A
Cucci, MA
Barbero, P
Pipieri, A
Clerico, M
Giordano, L
Delfico, L
Tassinari, T
Motti, L
Paciello, M
Reggio, A
Aimo, G
Durelli, L
机构：
来源：
MULTIPLE SCLEROSIS | 2004年 / 10卷 / 7032期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S251 / S251
页数：1
相关论文
共 50 条
  • [31] Ongoing efficacy and safety analysis of interferon-β1a (AVONEX) in patients with multiple sclerosis
    Herndon, RM
    Coats, M
    Goodkin, D
    Mass, M
    Richert, J
    Rudick, RA
    Weinstock-Guttman, B
    Simonian, NA
    Campion, M
    Scaramocci, J
    Alam, JJ
    Jacobs, LD
    ANNALS OF NEUROLOGY, 1997, 42 (06) : 987 - 987
  • [32] Occurrence of autoimmune events during treatment with two different dosages of subcutaneous interferon beta-1a (Rebif®) in multiple sclerosis:: the AUtoimmunity PRofile in INterferon beta (AUPRIN) study
    Giordano, L.
    Barbero, P.
    Clerico, M.
    Pipieri, A.
    Versino, E.
    Ferrero, B.
    Contessa, G.
    Delfico, L.
    Durelli, L.
    MULTIPLE SCLEROSIS, 2006, 12 : S208 - S208
  • [33] Subcutaneous Recombinant Interferon-β-1a (Rebif®) A Review of its Use in the Treatment of Relapsing Multiple Sclerosis
    Sanford, Mark
    Lyseng-Williamson, Katherine A.
    DRUGS, 2011, 71 (14) : 1865 - 1891
  • [34] Subcutaneous Recombinant Interferon-β-1a (Rebif®)A Review of its Use in the Treatment of Relapsing Multiple Sclerosis
    Mark Sanford
    Katherine A. Lyseng-Williamson
    Drugs, 2011, 71 : 1865 - 1891
  • [35] Interferon-β-1a/interferon-β-1bMultiple sclerosis exacerbation: 9 case reports
    Reactions Weekly, 2012, 1394 (1) : 27 - 27
  • [36] INTERFERON-β 1A, AN IMMUNOMODULATOR IN RELAPSING REMITTING MULTIPLE SCLEROSIS PATIENTS. THE EFFECT ON PRO-INFLAMMATORY CYTOKINES
    Maier, Smaranda
    Motataianu, Anca
    Barcutean, Laura
    Balint, Alina
    Hutanu, Adina
    Zoltan, Bajko
    Stoian, Adina
    Romaniuc, Andreea
    Andone, Sebastian
    Balasa, Rodica
    FARMACIA, 2020, 68 (01) : 65 - 75
  • [37] Real-world use of subcutaneous interferon β-1a in patients with relapsing multiple sclerosis
    Beckmann, Yesim
    Uzunkopru, Cihat
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP68 - NP69
  • [38] Dynamics of happiness and personal growth in multiple sclerosis patients treated with interferon-β-1a compared with healthy subjects
    Mazeh, D.
    Barak, Y.
    Achiron, A.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 486 - 486
  • [39] Interferon β-1a and Atorvastatin in the Treatment of Multiple Sclerosis
    Ghasami, Keyvan
    Faraji, Fardin
    Fazeli, Masoud
    Ghazavi, Ali
    Mosayebi, Ghasem
    IRANIAN JOURNAL OF IMMUNOLOGY, 2016, 13 (01) : 16 - 26
  • [40] Neuropsychological effects of Avonex® (interferon-β-1a) in relapsing multiple sclerosis (MS)
    Fischer, JS
    Priore, R
    Jacobs, L
    Cookfair, D
    Rudick, R
    Herndon, R
    Richert, J
    Salazar, A
    Goodkin, D
    Granger, C
    Simon, J
    Grafman, J
    Lezak, M
    O'Reilly, K
    Schacter, M
    Shucard, D
    Davidson, A
    Wende, K
    NEUROLOGY, 1998, 50 (04) : A32 - A33
12345